Products
MDL® Discovery Framework
MDL® Discovery Experiment Management
  MDL® Discovery Knowledge
   BiotechSelect
   Web Services
 
#  Bioactivity Databases
   MDL® Comprehensive Medicinal Chemistry
   MDL® Drug Data Report
   National Cancer Institute Databases
 
#  Chemical Sourcing
   MDL® Available Chemicals Directory
   MDL® Screening Compounds Directory (formerly ACD-SC)
 
#  Content Browsing
   DiscoveryGate®
   MDL® Reaction Browser
 
#  Metabolism and Toxicology
   MDL® Metabolite Database
   MDL® Toxicity Database
 
#  Patent Databases
   MDL® Drug Data Report
 
#  Synthetic Methodology Databases
   ChemInform Reaction Library
   Current Synthetic Methodology
   Derwent Journal of Synthetic Methods
   MDL® Reference Library of Synthetic Methodology
   MDL® Solid-Phase Organic Reactions
   ORGSYN Database
MDL® Discovery Predictive Science
Home > MDL® Discovery Knowledge > MDL® Drug Data Report
 
Discovery Knowledge
Key Features
System Requirements
How to Buy
MDL® Drug Data Report | Printer Friendly    
MDL Drug Data Report is a database covering the patent literature, journals, meetings and congresses. Produced by MDL and Prous Science, the database contains over 132,000 biologically relevant compounds and well-defined derivatives, with updates adding about 10,000 a year to the database.

Buy Online Request Free Evaluation
Click to Enlarge
Click to Enlarge

Search for compounds and view records using DiscoveryGateSM

With MDL® Drug Data Report, scientists can search drugs launched or under development and view therapeutic action and biological activity from more than 100,000 biologically relevant compounds and well-defined derivatives. Using MDL® ISIS/Base or MDL® Database Browser via DiscoveryGate, scientists are able to track compounds through development phases and view records derived from patent literature, journals, meetings and congresses.

     
     
Click to Enlarge
Click to Enlarge

Search for compounds and view records using MDL ISIS/Base

With MDL® Drug Data Report, scientists can search drugs launched or under development and view therapeutic action and biological activity from more than 100,000 biologically relevant compounds and well-defined derivatives. Using MDL® ISIS/Base or MDL® Database Browser via DiscoveryGate, scientists are able to track compounds through development phases and view records derived from patent literature, journals, meetings and congresses.

Additional Info

MDL Data Data Report datasheet (PDF)

Overview of Available Databases (PDF)

 
What's New
 
Events:
 
27-Aug-08
Managing analytical data with an electronic notebook in a team environment
 
28-Aug-08
Make better scientific decisions faster with the MDL ISIS replacement - the New Isentris 3.1
 
08-Sep-08
ChemOutsourcing Conference
 
 
Press Releases:
 
20-Aug-08
Symyx Facilitates ISIS-to-Isentris® Migrations
 
14-Aug-08
Symyx Technologies Acquires Integrity Biosolution
 
06-Aug-08
Symyx Enhances Software with OpenEye Technology
 
 
 
Related Product
CrossFire Beilstein
MDL® Comprehensive Medicinal Chemistry
National Cancer Institute Databases
DiscoveryGate®
MDL® ISIS/Host
MDL® ISIS/Base
MDL® ISIS/Draw
 
 
 
Status: 'Not Logged In.' Language Home Directory: '' Server: 'curly' Sessionid: 'C590DD2915DC9F981507097B96552BC8'